Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
OECD: Expects the Federal Reserve to "gradually" lower the key interest rate to 3.25% to 3.5%
Asset Management Giant Tidal Investments Acquires Approximately $60 Million in Strategy Stock
A certain whale with a significant BTC short position is planning to long at around $67,000, with the shorts currently showing a profit of $26.83 million.
Wintermute: Market Structure is Improving, Mainstream Tokens are No Longer Fragile
A Whale Holding Strong on 'Shorting Shitcoins' Nets $6.417 Million in Unrealized Gains, Account's Total Profit Tops $78.86 Million
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]